CAS: 153205-46-0 - Asimadoline
Formel:C27H30N2O2
InChl:InChI=1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1
InChI Key:InChIKey=JHLHNYVMZCADTC-LOSJGSFVSA-N
SMILES:O=C(N(C)C(C=1C=CC=CC1)CN2CCC(O)C2)C(C=3C=CC=CC3)C=4C=CC=CC4
- Synonyme:
- Asimadoline [INN]
- Benzeneacetamide, N-((1S)-2-((3S)-3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-
- Benzeneacetamide, N-(2-(3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-, (S-(R*,R*))-
- Benzeneacetamide, N-[(1S)-2-[(3S)-3-hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-α-phenyl-
- Benzeneacetamide, N-[2-(3-hydroxy-1-pyrrolidinyl)-1-phenylethyl]-N-methyl-α-phenyl-, [S-(R*,R*)]-
- Emd 61753
- N-((alpha S)-alpha-((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide
- N-((alphaS)-alpha-(((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide
- N-[(1S)-2-[(3S)-3-Hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-α-phenylbenzeneacetamide
- N-{(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl}-N-methyl-2,2-diphenylacetamide
- Mehr Synonyme anzeigen
- Unii-D0Vk52Nv5M
- Asimadoline
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
ASIMADOLINE REF: IN-DA00APIHCAS: 153205-46-0 | 98% | Nachfragen | Mi 27 Nov 24 | |
Asimadoline REF: TM-T4633CAS: 153205-46-0 | - - - | 73,00 €~278,00 € | Mo 02 Dez 24 | |
Asimadoline REF: 4Z-A-210001CAS: 153205-46-0 | - - - | Nachfragen | Mi 04 Dez 24 | |
Asimadoline REF: 3D-DGA20546CAS: 153205-46-0 | Min. 95% | Nachfragen | Mi 08 Jan 25 |
ASIMADOLINE
Ref: IN-DA00APIH
5mg | 162,00 € | ||
25mg | 625,00 € | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Asimadoline
Ref: TM-T4633
5mg | 73,00 € | ||
25mg | 278,00 € | ||
1mL*10mM (DMSO) | 79,00 € |
Ref: 4Z-A-210001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Asimadoline
Ref: 3D-DGA20546
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen |